Stock Scorer
Stock Board CompareNew Screen Insiders ETFNew
Donate
…
Report Measures Companies Earnings calendar Insider buying Fund portfolios Congress trades ETFs
Sign in

Travere Therapeutics, Inc. (TVTX) · Insider trading

What Travere Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$104.24M
11 insiders, 99% under a plan
Net, 12 months
−$104.24M
bought less sold
Latest filing
2026-09-17
filings read to 2026-10-20

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $221,247 sold 2024-12: $258,300 sold 2025-01: $735,389 sold 2025-01 2025-02: $4.12M sold 2025-05: $644,067 sold 2025-07: $11,940 sold 2025-07 2025-08: $8,136 sold 2025-09: $260,608 sold 2025-10: $4.54M sold 2025-11: $2.42M sold 2025-12: $4.34M sold 2026-01: $2.18M sold 2026-01 2026-02: $6.99M sold 2026-03: $280,900 sold 2026-04: $11.18M sold 2026-05: $4.58M sold 2026-06: $725,700 sold 2026-07 2026-08: $632,868 sold 2026-09: $66.38M sold
Bought Sold Largest month: $66.38M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER – $43.25M 25 2026-09-17 439,688
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER – $19.28M 18 2026-09-17 117,066
Rote William e.Chief Research Officer – $16.84M 14 2026-09-16 145,943
Reed Elizabeth eChief Legal Officer and GC – $7.78M 24 2026-09-15 120,963
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER – $6.11M 17 2026-09-15 43,453
Inrig JulaEVP, Head of R&D & CMO – $5.38M 21 2026-09-15 119,775
Cline Christopher R.CHIEF FINANCIAL OFFICER – $4.82M 22 2026-09-15 110,543
Baynes Roy D.Director – $3.09M 8 2026-06-12 41,500
Meckler Jeffrey ADirector – $1.71M 5 2026-09-10 109,800
Coughlin TimothyDirector – $1.27M 3 2026-06-12 56,250
Lyons Gary ADirector – $961,428 6 2026-08-18 62,400

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-17 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 101,691 64.59 $6.57M 439,688 Form 4
2026-09-17 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 6,802 64.95 $441,790 432,886 Form 4
2026-09-17 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 8,282 65.07 $538,910 117,066 Form 4
2026-09-16 Rote William e.Chief Research Officer Saleplan 65,104 63.12 $4.11M 145,943 Form 4
2026-09-16 Rote William e.Chief Research Officer Saleplan 47,746 63.61 $3.04M 98,197 Form 4
2026-09-16 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 99,716 63.26 $6.31M 529,011 Form 4
2026-09-16 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 96,125 63.64 $6.12M 432,886 Form 4
2026-09-16 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 93,604 63.25 $5.92M 196,179 Form 4
2026-09-16 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 79,113 63.65 $5.04M 117,066 Form 4
2026-09-15 Reed Elizabeth eChief Legal Officer and GC Saleplan 21,926 62.03 $1.36M 120,963 Form 4
2026-09-15 Reed Elizabeth eChief Legal Officer and GC Saleplan 13,874 62.63 $868,929 107,089 Form 4
2026-09-15 Reed Elizabeth eChief Legal Officer and GC Saleplan 1,400 63.69 $89,166 105,689 Form 4
2026-09-15 Reed Elizabeth eChief Legal Officer and GC Saleplan 300 65.31 $19,593 105,389 Form 4
2026-09-15 Rote William e.Chief Research Officer Saleplan 63,907 61.99 $3.96M 130,488 Form 4
2026-09-15 Rote William e.Chief Research Officer Saleplan 29,021 62.66 $1.82M 101,467 Form 4
2026-09-15 Rote William e.Chief Research Officer Saleplan 3,000 63.65 $190,950 98,467 Form 4
2026-09-15 Rote William e.Chief Research Officer Saleplan 270 65.31 $17,634 98,197 Form 4
2026-09-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 63,498 61.99 $3.94M 465,054 Form 4
2026-09-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 28,796 62.66 $1.80M 436,258 Form 4
2026-09-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 3,102 63.64 $197,411 433,156 Form 4
2026-09-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 270 65.31 $17,634 432,886 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 71,938 62.05 $4.46M 147,318 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 27,421 62.59 $1.72M 119,897 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 1,400 63.65 $89,110 118,497 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Saleplan 1,431 65.31 $93,459 117,066 Form 4
2026-09-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 4,275 62.14 $265,648 43,453 Form 4
2026-09-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 800 62.85 $50,280 42,653 Form 4
2026-09-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 300 63.66 $19,098 42,353 Form 4
2026-09-15 Inrig JulaEVP, Head of R&D & CMO Saleplan 25,390 62.02 $1.57M 119,775 Form 4
2026-09-15 Inrig JulaEVP, Head of R&D & CMO Saleplan 17,284 62.62 $1.08M 102,491 Form 4
2026-09-15 Inrig JulaEVP, Head of R&D & CMO Saleplan 1,600 63.69 $101,904 100,891 Form 4
2026-09-15 Inrig JulaEVP, Head of R&D & CMO Saleplan 400 65.31 $26,124 100,491 Form 4
2026-09-15 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 27,473 62.00 $1.70M 110,543 Form 4
2026-09-15 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 20,735 62.61 $1.30M 89,808 Form 4
2026-09-15 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 1,900 63.69 $121,011 87,908 Form 4
2026-09-15 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 400 65.31 $26,124 87,508 Form 4
2026-09-10 Meckler Jeffrey ADirector Saleplan 1,700 65.39 $111,163 109,800 Form 4
2026-09-10 Meckler Jeffrey ADirector Saleplan 1,200 66.15 $79,380 108,600 Form 4
2026-09-10 Meckler Jeffrey ADirector Saleplan 14,000 67.46 $944,440 94,600 Form 4
2026-09-10 Meckler Jeffrey ADirector Saleplan 3,100 68.09 $211,079 91,500 Form 4
123 more
2026-09-02 Cline Christopher R.CHIEF FINANCIAL OFFICER Sale 642 66.37 $42,610 118,016 Form 4
2026-08-18 Lyons Gary ADirector Saleplan 4,100 63.27 $259,407 62,400 Form 4
2026-08-18 Lyons Gary ADirector Saleplan 900 63.86 $57,474 61,500 Form 4
2026-08-17 Lyons Gary ADirector Saleplan 1,900 62.53 $118,807 64,600 Form 4
2026-08-17 Lyons Gary ADirector Saleplan 2,600 63.50 $165,100 62,000 Form 4
2026-08-17 Lyons Gary ADirector Saleplan 500 64.16 $32,080 61,500 Form 4
2026-06-12 Coughlin TimothyDirector Saleplan 10,000 50.07 $500,700 56,250 Form 4
2026-06-12 Baynes Roy D.Director Saleplan 4,500 50.00 $225,000 41,500 Form 4
2026-05-15 Coughlin TimothyDirector Saleplan 3,250 43.49 $141,342 52,250 Form 4
2026-05-06 Reed Elizabeth eChief Legal Officer and GC Saleplan 2,076 43.95 $91,240 105,211 Form 4
2026-05-06 Rote William e.Chief Research Officer Saleplan 2,763 43.95 $121,434 115,474 Form 4
2026-05-06 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 22,500 43.95 $988,875 432,886 Form 4
2026-05-06 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 311 43.95 $13,668 113,238 Form 4
2026-05-06 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 310 43.95 $13,624 118,658 Form 4
2026-05-05 Reed Elizabeth eChief Legal Officer and GC Saleplan 2,174 46.65 $101,417 107,287 Form 4
2026-05-05 Baynes Roy D.Director Saleplan 4,500 46.65 $209,925 37,500 Form 4
2026-05-05 Heerma PeterCHIEF COMMERCIAL OFFICER Sale 2,174 46.65 $101,417 140,684 Form 4
2026-05-05 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 2,174 46.65 $101,417 113,549 Form 4
2026-05-05 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 2,181 46.65 $101,744 118,968 Form 4
2026-05-04 Reed Elizabeth eChief Legal Officer and GC Saleplan 20,000 45.00 $900,000 105,211 Form 4
2026-05-04 Meckler Jeffrey ADirector Saleplan 8,000 45.00 $360,000 87,500 Form 4
2026-05-04 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 20,000 45.00 $900,000 111,473 Form 4
2026-05-01 Baynes Roy D.Director Saleplan 9,750 44.22 $431,145 37,500 Form 4
2026-04-22 Rote William e.Chief Research Officer Saleplan 9,100 39.09 $355,719 113,987 Form 4
2026-04-15 Reed Elizabeth eChief Legal Officer and GC Saleplan 5,226 41.62 $217,506 106,770 Form 4
2026-04-15 Reed Elizabeth eChief Legal Officer and GC Saleplan 1,559 42.53 $66,304 105,211 Form 4
2026-04-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 56,815 41.01 $2.33M 440,071 Form 4
2026-04-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 7,165 41.75 $299,139 432,906 Form 4
2026-04-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 20 42.66 $853 432,886 Form 4
2026-04-15 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 1,018 42.61 $43,377 111,473 Form 4
2026-04-15 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 1,014 42.61 $43,207 116,899 Form 4
2026-04-14 Lyons Gary ADirector Saleplan 8,000 41.07 $328,560 57,500 Form 4
2026-04-14 Baynes Roy D.Director Saleplan 26,000 41.07 $1.07M 44,250 Form 4
2026-04-14 Baynes Roy D.Director Saleplan 6,750 42.12 $284,310 37,500 Form 4
2026-04-14 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 21,977 41.07 $902,595 42,353 Form 4
2026-04-14 Reed Elizabeth eChief Legal Officer and GC Saleplan 37,500 41.07 $1.54M 119,211 Form 4
2026-04-14 Reed Elizabeth eChief Legal Officer and GC Saleplan 7,215 41.93 $302,525 111,996 Form 4
2026-04-14 Heerma PeterCHIEF COMMERCIAL OFFICER Sale 7,215 41.93 $302,525 138,608 Form 4
2026-04-14 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 7,215 41.93 $302,525 112,491 Form 4
2026-04-14 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 9 41.07 $370 125,152 Form 4
2026-04-14 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 7,239 41.93 $303,531 117,913 Form 4
2026-04-13 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 65 28.85 $1,875 125,161 Form 4
2026-04-06 Baynes Roy D.Director Saleplan 10,000 33.00 $330,000 37,500 Form 4
2026-04-01 Reed Elizabeth eChief Legal Officer and GC Saleplan 10,000 30.00 $300,000 105,211 Form 4
2026-04-01 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 34,902 30.55 $1.07M 457,984 Form 4
2026-04-01 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 25,098 31.46 $789,583 432,886 Form 4
2026-03-16 Reed Elizabeth eChief Legal Officer and GC Saleplan 10,000 28.09 $280,900 105,211 Form 4
2026-02-20 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 60,000 30.10 $1.81M 432,886 Form 4
2026-02-17 Reed Elizabeth eChief Legal Officer and GC Saleplan 5,679 27.50 $156,172 109,532 Form 4
2026-02-17 Reed Elizabeth eChief Legal Officer and GC Saleplan 4,321 28.26 $122,111 105,211 Form 4
2026-02-04 Reed Elizabeth eChief Legal Officer and GC Saleplan 2,485 32.07 $79,694 105,720 Form 4
2026-02-04 Reed Elizabeth eChief Legal Officer and GC Saleplan 509 32.74 $16,665 105,211 Form 4
2026-02-04 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 1,547 32.11 $49,674 105,938 Form 4
2026-02-04 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 232 32.85 $7,621 105,706 Form 4
2026-02-04 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 1,635 32.14 $52,549 111,336 Form 4
2026-02-04 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 110 32.90 $3,619 111,226 Form 4
2026-02-03 Reed Elizabeth eChief Legal Officer and GC Sale 7,175 32.12 $230,461 108,205 Form 4
2026-02-03 Rote William e.Chief Research Officer Saleplan 12,446 32.87 $409,100 109,087 Form 4
2026-02-03 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 66,452 32.06 $2.13M 466,521 Form 4
2026-02-03 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 33,635 32.70 $1.10M 432,886 Form 4
2026-02-03 Heerma PeterCHIEF COMMERCIAL OFFICER Sale 7,310 32.12 $234,797 131,823 Form 4
2026-02-03 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Sale 4,333 32.12 $139,176 49,080 Form 4
2026-02-03 Inrig JulaCHIEF MEDICAL OFFICER Sale 6,956 32.12 $223,427 107,485 Form 4
2026-02-03 Cline Christopher R.CHIEF FINANCIAL OFFICER Sale 7,242 32.12 $232,613 112,971 Form 4
2026-01-27 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 51,865 30.10 $1.56M 419,173 Form 4
2026-01-23 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 8,135 30.01 $244,131 419,173 Form 4
2026-01-20 Reed Elizabeth eChief Legal Officer and GC Saleplan 10,000 27.34 $273,400 90,270 Form 4
2026-01-06 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 445 37.75 $16,799 86,311 Form 4
2026-01-05 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 2,031 40.18 $81,606 86,756 Form 4
2025-12-24 Rote William e.Chief Research Officer Saleplan 60,000 40.10 $2.41M 101,443 Form 4
2025-12-24 Heerma PeterCHIEF COMMERCIAL OFFICER Saleplan 4,980 40.00 $199,200 113,013 Form 4
2025-12-24 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 7,402 40.00 $296,080 38,233 Form 4
2025-12-24 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 15,000 42.00 $630,000 88,787 Form 4
2025-12-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 2,910 36.00 $104,760 45,635 Form 4
2025-12-01 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 20,000 35.01 $700,200 92,083 Form 4
2025-11-04 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 67,115 36.00 $2.42M 48,545 Form 4
2025-10-31 Coughlin TimothyDirector Saleplan 18,000 35.03 $630,540 55,500 Form 4
2025-10-31 Heerma PeterCHIEF COMMERCIAL OFFICER Saleplan 5,591 35.00 $195,685 119,071 Form 4
2025-10-29 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 27,128 30.12 $817,095 419,173 Form 4
2025-10-28 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 92,872 30.38 $2.82M 419,173 Form 4
2025-10-28 Heerma PeterCHIEF COMMERCIAL OFFICER Saleplan 2,662 30.00 $79,860 124,662 Form 4
2025-09-22 Reed Elizabeth eChief Legal Officer and GC Saleplan 10,000 25.00 $250,000 89,878 Form 4
2025-09-04 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 119 19.71 $2,345 92,083 Form 4
2025-09-03 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 454 18.20 $8,263 92,202 Form 4
2025-08-27 Cline Christopher R.CHIEF FINANCIAL OFFICER Saleplan 470 17.31 $8,136 92,656 Form 4
2025-07-01 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 815 14.65 $11,940 88,787 Form 4
2025-05-05 Reed Elizabeth eChief Legal Officer and GC Saleplan 4,920 21.05 $103,566 89,482 Form 4
2025-05-05 Rote William e.Chief Research Officer Saleplan 3,198 21.05 $67,318 100,241 Form 4
2025-05-05 Heerma PeterCHIEF COMMERCIAL OFFICER Sale 1,771 21.05 $37,280 128,215 Form 4
2025-05-05 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 18,924 21.05 $398,350 419,173 Form 4
2025-05-05 Cline Christopher R.CHIEF FINANCIAL OFFICER Sale 1,784 21.05 $37,553 93,126 Form 4
2025-04-11 Cline Christopher R.CHIEF FINANCIAL OFFICER Sale 48 13.14 $631 89,990 Form 4
2025-02-12 Inrig JulaCHIEF MEDICAL OFFICER Sale 2,568 23.53 $60,425 89,602 Form 4
2025-02-12 Heerma PeterCHIEF COMMERCIAL OFFICER Saleplan 2,568 23.53 $60,425 125,066 Form 4
2025-02-12 Reed Elizabeth eSVP, GC & CORPORATE SECRETARY Saleplan 8,000 23.53 $188,240 89,482 Form 4
2025-02-12 Rote William e.SENIOR VICE PRESIDENT, R&D Saleplan 5,200 23.53 $122,356 98,519 Form 4
2025-02-11 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 11,375 24.04 $273,455 419,173 Form 4
2025-02-11 Heerma PeterCHIEF COMMERCIAL OFFICER Saleplan 3,074 25.00 $76,850 127,634 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 10,000 25.00 $250,000 63,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 10,000 25.00 $250,000 63,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 10,000 25.00 $250,000 63,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 15,000 25.00 $375,000 63,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 9,244 25.00 $231,100 54,410 Form 4
2025-02-06 Baynes Roy D.Director Saleplan 10,000 22.00 $220,000 31,000 Form 4
2025-02-04 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 1,066 20.11 $21,437 84,170 Form 4
2025-02-03 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Sale 3,348 20.12 $67,362 63,654 Form 4
2025-02-03 Cline Christopher R.CHIEF FINANCIAL OFFICER Sale 5,192 20.12 $104,463 90,038 Form 4
2025-02-03 Heerma PeterCHIEF COMMERCIAL OFFICER Sale 5,166 20.12 $103,940 122,708 Form 4
2025-02-03 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 4,207 20.12 $84,645 85,236 Form 4
2025-02-03 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 50,691 20.21 $1.02M 430,548 Form 4
2025-02-03 Reed Elizabeth eSVP, GC & CORPORATE SECRETARY Saleplan 8,951 19.78 $177,051 89,482 Form 4
2025-02-03 Rote William e.SENIOR VICE PRESIDENT, R&D Saleplan 8,951 19.78 $177,051 95,719 Form 4
2025-01-23 Baynes Roy D.Director Saleplan 16,000 20.00 $320,000 31,000 Form 4
2025-01-22 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Sale 925 18.94 $17,520 54,002 Form 4
2025-01-22 Cline Christopher R.CHIEF FINANCIAL OFFICER Sale 865 18.94 $16,383 73,730 Form 4
2025-01-22 Heerma PeterCHIEF COMMERCIAL OFFICER Sale 1,584 18.94 $30,001 106,374 Form 4
2025-01-22 Reed Elizabeth eSVP, GC & CORPORATE SECRETARY Saleplan 2,437 19.46 $47,424 76,933 Form 4
2025-01-22 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Saleplan 10,736 19.46 $208,923 351,239 Form 4
2025-01-22 Rote William e.SENIOR VICE PRESIDENT, R&D Saleplan 2,437 19.46 $47,424 83,170 Form 4
2025-01-06 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 440 18.76 $8,254 59,443 Form 4
2025-01-03 Inrig JulaCHIEF MEDICAL OFFICER Saleplan 2,066 19.10 $39,461 59,883 Form 4
2024-12-26 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Saleplan 15,000 17.22 $258,300 54,927 Form 4
2024-11-25 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Sale 12,090 18.30 $221,247 54,927 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

89 × option exercise38 × grant or award3 × gift
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-17 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +108,493 23.34 541,379 Form 4
2026-09-17 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +8,282 22.40 125,348 Form 4
2026-09-16 Rote William e.Chief Research Officer Option exercise M +350 17.96 98,547 Form 4
2026-09-16 Rote William e.Chief Research Officer Option exercise M +55,000 15.46 153,547 Form 4
2026-09-16 Rote William e.Chief Research Officer Option exercise M +57,500 26.88 211,047 Form 4
2026-09-16 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +195,841 23.34 628,727 Form 4
2026-09-16 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +100,000 11.25 217,066 Form 4
2026-09-16 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +55,000 15.46 272,066 Form 4
2026-09-16 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +17,717 26.88 289,783 Form 4
2026-09-15 Reed Elizabeth eChief Legal Officer and GC Option exercise M +37,500 15.46 142,889 Form 4
2026-09-15 Rote William e.Chief Research Officer Option exercise M +39,000 25.25 154,745 Form 4
2026-09-15 Rote William e.Chief Research Officer Option exercise M +39,650 17.96 194,395 Form 4
2026-09-15 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +95,666 23.34 528,552 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +39,283 26.88 181,349 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +1,381 22.40 182,730 Form 4
2026-09-15 Heerma PeterEVP, CHIEF COMMERCIAL OFFICER Option exercise M +36,526 8.93 219,256 Form 4
2026-09-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +2,500 27.50 44,853 Form 4
2026-09-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +1,250 22.40 46,103 Form 4
2026-09-15 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +1,625 20.46 47,728 Form 4
2026-09-15 Inrig JulaEVP, Head of R&D & CMO Option exercise M +32,395 8.93 145,165 Form 4
2026-09-15 Cline Christopher R.CHIEF FINANCIAL OFFICER Option exercise M +20,000 17.44 138,016 Form 4
2026-09-10 Meckler Jeffrey ADirector Option exercise M +10,000 17.44 101,500 Form 4
2026-09-10 Meckler Jeffrey ADirector Option exercise M +10,000 26.52 111,500 Form 4
2026-08-18 Lyons Gary ADirector Option exercise M +5,000 17.44 66,500 Form 4
2026-08-17 Lyons Gary ADirector Option exercise M +5,000 17.44 66,500 Form 4
2026-06-22 Inrig JulaCHIEF MEDICAL OFFICER Gift G −468 – 112,770 Form 4
2026-06-12 Coughlin TimothyDirector Option exercise M +10,000 26.52 66,250 Form 4
2026-06-12 Baynes Roy D.Director Option exercise M +4,500 21.38 46,000 Form 4
2026-05-19 Lyons Gary ADirector Grant or award A +4,000 – 61,500 Form 4
2026-05-19 Williams Brinkley RuthDirector Grant or award A +4,000 – 29,750 Form 4
2026-05-19 Coughlin TimothyDirector Grant or award A +4,000 – 56,250 Form 4
2026-05-19 Squarer RonDirector Grant or award A +4,000 – 39,375 Form 4
2026-05-19 Orwin John ADirector Grant or award A +4,000 – 39,375 Form 4
2026-05-19 Meckler Jeffrey ADirector Grant or award A +4,000 – 91,500 Form 4
2026-05-19 Bruhn Suzanne LouiseDirector Grant or award A +4,000 – 32,750 Form 4
2026-05-19 Poole SandraDirector Grant or award A +4,000 – 34,000 Form 4
2026-05-19 Baynes Roy D.Director Grant or award A +4,000 – 41,500 Form 4
2026-05-05 Baynes Roy D.Director Option exercise M +4,500 18.27 42,000 Form 4
2026-05-04 Reed Elizabeth eChief Legal Officer and GC Option exercise M +20,000 17.96 125,211 Form 4
2026-05-04 Reed Elizabeth eChief Legal Officer and GC Option exercise M +4,250 – 109,461 Form 4
2026-05-04 Meckler Jeffrey ADirector Option exercise M +8,000 16.33 95,500 Form 4
2026-05-04 Rote William e.Chief Research Officer Option exercise M +4,250 – 118,237 Form 4
2026-05-04 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +22,500 – 455,386 Form 4
2026-05-04 Heerma PeterCHIEF COMMERCIAL OFFICER Option exercise M +4,250 – 142,858 Form 4
2026-05-04 Inrig JulaCHIEF MEDICAL OFFICER Option exercise M +20,000 22.40 131,473 Form 4
2026-05-04 Inrig JulaCHIEF MEDICAL OFFICER Option exercise M +4,250 – 115,723 Form 4
2026-05-04 Cline Christopher R.CHIEF FINANCIAL OFFICER Option exercise M +4,250 – 121,149 Form 4
2026-05-01 Baynes Roy D.Director Option exercise M +9,750 6.82 47,250 Form 4
2026-04-14 Lyons Gary ADirector Option exercise M +8,000 16.33 65,500 Form 4
2026-04-14 Baynes Roy D.Director Option exercise M +8,000 17.94 45,500 Form 4
2026-04-14 Baynes Roy D.Director Option exercise M +9,000 15.43 54,500 Form 4
2026-04-14 Baynes Roy D.Director Option exercise M +4,500 18.27 59,000 Form 4
2026-04-14 Baynes Roy D.Director Option exercise M +4,500 21.38 63,500 Form 4
2026-04-14 Baynes Roy D.Director Option exercise M +6,750 17.11 70,250 Form 4
2026-04-14 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +2,500 22.40 51,580 Form 4
2026-04-14 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +6,250 8.93 57,830 Form 4
2026-04-14 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +6,500 20.46 64,330 Form 4
2026-04-14 Reed Elizabeth eChief Legal Officer and GC Option exercise M +10,000 19.08 129,211 Form 4
2026-04-14 Reed Elizabeth eChief Legal Officer and GC Option exercise M +20,000 17.96 149,211 Form 4
2026-04-14 Reed Elizabeth eChief Legal Officer and GC Option exercise M +7,500 15.46 156,711 Form 4
2026-04-13 Reed Elizabeth eChief Legal Officer and GC Grant or award A +14,000 – 119,211 Form 4
2026-04-13 Rote William e.Chief Research Officer Grant or award A +14,000 – 123,087 Form 4
2026-04-13 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Grant or award A +64,000 – 496,886 Form 4
2026-04-13 Heerma PeterCHIEF COMMERCIAL OFFICER Grant or award A +14,000 – 145,823 Form 4
2026-04-13 Inrig JulaCHIEF MEDICAL OFFICER Grant or award A +14,000 – 119,706 Form 4
2026-04-13 Cline Christopher R.CHIEF FINANCIAL OFFICER Grant or award A +14,000 – 125,226 Form 4
2026-04-06 Baynes Roy D.Director Option exercise M +10,000 26.52 47,500 Form 4
2026-04-01 Reed Elizabeth eChief Legal Officer and GC Option exercise M +10,000 15.46 115,211 Form 4
2026-04-01 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +60,000 15.46 492,886 Form 4
2026-03-16 Reed Elizabeth eChief Legal Officer and GC Option exercise M +10,000 19.08 115,211 Form 4
2026-02-20 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +60,000 15.46 492,886 Form 4
2026-02-17 Reed Elizabeth eChief Legal Officer and GC Option exercise M +10,000 19.08 115,211 Form 4
2026-01-31 Reed Elizabeth eChief Legal Officer and GC Grant or award A +25,110 – 115,380 Form 4
2026-01-31 Rote William e.Chief Research Officer Grant or award A +20,090 – 121,533 Form 4
2026-01-31 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Grant or award A +113,800 – 532,973 Form 4
2026-01-31 Heerma PeterCHIEF COMMERCIAL OFFICER Grant or award A +26,120 – 139,133 Form 4
2026-01-31 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Grant or award A +15,180 – 53,413 Form 4
2026-01-31 Inrig JulaCHIEF MEDICAL OFFICER Grant or award A +28,130 – 114,441 Form 4
2026-01-31 Cline Christopher R.CHIEF FINANCIAL OFFICER Grant or award A +28,130 – 120,213 Form 4
2026-01-27 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +51,865 15.46 471,038 Form 4
2026-01-23 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +8,135 15.46 427,308 Form 4
2026-01-20 Reed Elizabeth eChief Legal Officer and GC Option exercise M +10,000 19.08 100,270 Form 4
2025-12-24 Rote William e.Chief Research Officer Option exercise M +60,000 20.61 161,443 Form 4
2025-12-24 Inrig JulaCHIEF MEDICAL OFFICER Option exercise M +15,000 8.93 103,787 Form 4
2025-12-01 Cline Christopher R.CHIEF FINANCIAL OFFICER Option exercise M +20,000 16.23 112,083 Form 4
2025-11-04 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +10,000 25.25 64,410 Form 4
2025-11-04 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +17,500 26.88 81,910 Form 4
2025-11-04 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +15,000 27.50 96,910 Form 4
2025-11-04 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +12,500 22.40 109,410 Form 4
2025-11-04 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +6,250 8.93 115,660 Form 4
2025-11-03 Heerma PeterCHIEF COMMERCIAL OFFICER Gift G −1,078 – 117,993 Form 4
2025-10-31 Coughlin TimothyDirector Option exercise M +8,000 16.33 63,500 Form 4
2025-10-31 Coughlin TimothyDirector Option exercise M +10,000 17.44 73,500 Form 4
2025-10-29 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +27,128 15.46 446,301 Form 4
2025-10-28 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +92,872 15.46 512,045 Form 4
2025-09-23 Heerma PeterCHIEF COMMERCIAL OFFICER Gift G −891 – 127,324 Form 4
2025-09-22 Reed Elizabeth eChief Legal Officer and GC Option exercise M +10,000 19.08 99,878 Form 4
2025-05-15 Baynes Roy D.Director Grant or award A +6,500 – 37,500 Form 4
2025-05-15 Bruhn Suzanne LouiseDirector Grant or award A +6,500 – 28,750 Form 4
2025-05-15 Coughlin TimothyDirector Grant or award A +6,500 – 55,500 Form 4
2025-05-15 Lyons Gary ADirector Grant or award A +6,500 – 57,500 Form 4
2025-05-15 Meckler Jeffrey ADirector Grant or award A +6,500 – 87,500 Form 4
2025-05-15 Orwin John ADirector Grant or award A +6,500 – 35,375 Form 4
2025-05-15 Poole SandraDirector Grant or award A +6,500 – 30,000 Form 4
2025-05-15 Squarer RonDirector Grant or award A +6,500 – 35,375 Form 4
2025-05-15 Williams Brinkley RuthDirector Grant or award A +6,500 – 25,750 Form 4
2025-05-02 Reed Elizabeth eChief Legal Officer and GC Option exercise M +4,920 – 94,402 Form 4
2025-05-02 Rote William e.Chief Research Officer Option exercise M +4,920 – 103,439 Form 4
2025-05-02 Heerma PeterCHIEF COMMERCIAL OFFICER Option exercise M +4,920 – 129,986 Form 4
2025-05-02 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Option exercise M +18,924 – 438,097 Form 4
2025-05-02 Cline Christopher R.CHIEF FINANCIAL OFFICER Option exercise M +4,920 – 94,910 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +10,000 16.23 73,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +10,000 17.44 73,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +10,000 17.96 73,654 Form 4
2025-02-11 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +15,000 15.46 78,654 Form 4
2025-02-10 Inrig JulaCHIEF MEDICAL OFFICER Option exercise M +8,000 – 92,170 Form 4
2025-02-10 Heerma PeterCHIEF COMMERCIAL OFFICER Option exercise M +8,000 – 130,708 Form 4
2025-02-10 Reed Elizabeth eSVP, GC & CORPORATE SECRETARY Option exercise M +8,000 – 97,482 Form 4
2025-02-10 Rote William e.SENIOR VICE PRESIDENT, R&D Option exercise M +8,000 – 103,719 Form 4
2025-02-06 Baynes Roy D.Director Option exercise M +10,000 17.44 41,000 Form 4
2025-01-31 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Grant or award A +13,000 – 67,002 Form 4
2025-01-31 Cline Christopher R.CHIEF FINANCIAL OFFICER Grant or award A +21,500 – 95,230 Form 4
2025-01-31 Heerma PeterCHIEF COMMERCIAL OFFICER Grant or award A +21,500 – 127,874 Form 4
2025-01-31 Inrig JulaCHIEF MEDICAL OFFICER Grant or award A +30,000 – 89,443 Form 4
2025-01-31 Dube Eric MDirector, CHIEF EXECUTIVE OFFICER Grant or award A +130,000 – 481,239 Form 4
2025-01-31 Reed Elizabeth eSVP, GC & CORPORATE SECRETARY Grant or award A +21,500 – 98,433 Form 4
2025-01-31 Rote William e.SENIOR VICE PRESIDENT, R&D Grant or award A +21,500 – 104,670 Form 4
2025-01-23 Baynes Roy D.Director Option exercise M +16,000 17.50 47,000 Form 4
2024-12-26 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +15,000 12.67 69,927 Form 4
2024-11-25 Calvin SandraSVP, CHIEF ACCOUNTING OFFICER Option exercise M +15,000 12.67 67,017 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Travere Therapeutics's scores and multiples ›